Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2005 3
2006 6
2007 1
2008 1
2009 6
2010 3
2011 4
2012 4
2013 4
2014 6
2015 5
2016 2
2017 6
2018 9
2019 11
2020 9
2021 16
2022 9
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.
Karikari TK, Ashton NJ, Brinkmalm G, Brum WS, Benedet AL, Montoliu-Gaya L, Lantero-Rodriguez J, Pascoal TA, Suárez-Calvet M, Rosa-Neto P, Blennow K, Zetterberg H. Karikari TK, et al. Among authors: brinkmalm g. Nat Rev Neurol. 2022 Jul;18(7):400-418. doi: 10.1038/s41582-022-00665-2. Epub 2022 May 18. Nat Rev Neurol. 2022. PMID: 35585226 Review.
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Schöll M, Massarweh G, Soucy JP, Höglund K, Brinkmalm G, Mattsson N, Palmqvist S, Gauthier S, Stomrud E, Zetterberg H, Hansson O, Rosa-Neto P, Blennow K. Karikari TK, et al. Among authors: brinkmalm g. Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5. Lancet Neurol. 2020. PMID: 32333900
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Schöll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H, Rosa-Neto P, Blennow K. Ashton NJ, et al. Among authors: brinkmalm g. Acta Neuropathol. 2021 May;141(5):709-724. doi: 10.1007/s00401-021-02275-6. Epub 2021 Feb 14. Acta Neuropathol. 2021. PMID: 33585983 Free PMC article.
Alzheimer's Disease Biomarker Analysis Using Targeted Mass Spectrometry.
Gobom J, Brinkmalm A, Brinkmalm G, Blennow K, Zetterberg H. Gobom J, et al. Among authors: brinkmalm g. Mol Cell Proteomics. 2024 Feb;23(2):100721. doi: 10.1016/j.mcpro.2024.100721. Epub 2024 Jan 20. Mol Cell Proteomics. 2024. PMID: 38246483 Free PMC article. Review.
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
Lennol MP, Sánchez-Domínguez I, Cuchillo-Ibañez I, Camporesi E, Brinkmalm G, Alcolea D, Fortea J, Lleó A, Soria G, Aguado F, Zetterberg H, Blennow K, Sáez-Valero J. Lennol MP, et al. Among authors: brinkmalm g. Alzheimers Res Ther. 2022 Nov 2;14(1):161. doi: 10.1186/s13195-022-01108-2. Alzheimers Res Ther. 2022. PMID: 36324176 Free PMC article.
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, Brinkmalm G, Hye A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: brinkmalm g. Biomark Med. 2018 Jul;12(7):799-812. doi: 10.2217/bmm-2017-0433. Epub 2018 Jun 15. Biomark Med. 2018. PMID: 29902934 Review.
Explorative and targeted neuroproteomics in Alzheimer's disease.
Brinkmalm A, Portelius E, Öhrfelt A, Brinkmalm G, Andreasson U, Gobom J, Blennow K, Zetterberg H. Brinkmalm A, et al. Among authors: brinkmalm g. Biochim Biophys Acta. 2015 Jul;1854(7):769-78. doi: 10.1016/j.bbapap.2015.01.009. Epub 2015 Jan 22. Biochim Biophys Acta. 2015. PMID: 25619854 Review.
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Alić I, Goh PA, Murray A, Portelius E, Gkanatsiou E, Gough G, Mok KY, Koschut D, Brunmeir R, Yeap YJ, O'Brien NL, Groet J, Shao X, Havlicek S, Dunn NR, Kvartsberg H, Brinkmalm G, Hithersay R, Startin C, Hamburg S, Phillips M, Pervushin K, Turmaine M, Wallon D, Rovelet-Lecrux A, Soininen H, Volpi E, Martin JE, Foo JN, Becker DL, Rostagno A, Ghiso J, Krsnik Ž, Šimić G, Kostović I, Mitrečić D; LonDownS Consortium; Francis PT, Blennow K, Strydom A, Hardy J, Zetterberg H, Nižetić D. Alić I, et al. Among authors: brinkmalm g. Mol Psychiatry. 2021 Oct;26(10):5766-5788. doi: 10.1038/s41380-020-0806-5. Epub 2020 Jul 10. Mol Psychiatry. 2021. PMID: 32647257 Free PMC article.
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.
Montoliu-Gaya L, Benedet AL, Tissot C, Vrillon A, Ashton NJ, Brum WS, Lantero-Rodriguez J, Stevenson J, Nilsson J, Sauer M, Rahmouni N, Brinkmalm G, Lussier FZ, Pascoal TA, Skoog I, Kern S, Zetterberg H, Paquet C, Gobom J, Rosa-Neto P, Blennow K. Montoliu-Gaya L, et al. Among authors: brinkmalm g. Nat Aging. 2023 Jun;3(6):661-669. doi: 10.1038/s43587-023-00405-1. Epub 2023 Apr 27. Nat Aging. 2023. PMID: 37198279 Free PMC article.
108 results